Lista de obras -

A Monovalent Chimpanzee Adenovirus Ebola Vaccine Boosted with MVA

artículo científico publicado en 2016

A Randomized, Blinded, Dose-Ranging Trial of an Ebola Virus Glycoprotein (EBOV GP) Nanoparticle Vaccine with Matrix-M™ Adjuvant in Healthy Adults

artículo científico publicado en 2019

Adjuvant formulated virus-like particles expressing native-like forms of the Lassa virus envelope surface glycoprotein are immunogenic and induce antibodies with broadly neutralizing activity

scientific article published on 04 August 2020

Corrigendum: Differential transcriptional responses to Ebola and Marburg virus infection in bat and human cells

artículo científico publicado en 2017

Cryo-electron tomography of Marburg virus particles and their morphogenesis within infected cells

artículo científico publicado en 2011

Detectable Vesicular Stomatitis Virus (VSV)-Specific Humoral and Cellular Immune Responses Following VSV-Ebola Virus Vaccination in Humans

article

Development of a Cost-effective Ovine Polyclonal Antibody-Based Product, EBOTAb, to Treat Ebola Virus Infection

artículo científico publicado en 2015

Development of an antibody capture ELISA using inactivated Ebola Zaire Makona virus

artículo científico publicado en 2015

Differential transcriptional responses to Ebola and Marburg virus infection in bat and human cells

artículo científico publicado en 2016

Dose-dependent T-cell Dynamics and Cytokine Cascade Following rVSV-ZEBOV Immunization

artículo científico publicado en 2017

Electron tomography reveals the steps in filovirus budding

artículo científico publicado en 2010

Epitopes of Naturally Acquired and Vaccine-induced Anti-Ebola Virus Glycoprotein Antibodies in Single Amino Acid Resolution

artículo científico publicado en 2020

Establishment of fruit bat cells (Rousettus aegyptiacus) as a model system for the investigation of filoviral infection

artículo científico publicado en 2010

Functional Characterization of Adaptive Mutations during the West African Ebola Virus Outbreak.

artículo científico publicado en 2016

Generation of therapeutic antisera for emerging viral infections

artículo científico publicado en 2018

Investigating the zoonotic origin of the West African Ebola epidemic

artículo científico publicado en 2015

Longitudinal Isolation of Potent Near-Germline SARS-CoV-2-Neutralizing Antibodies from COVID-19 Patients

artículo científico publicado en 2020

Longitudinal Isolation of Potent Near-Germline SARS-CoV-2-Neutralizing Antibodies from COVID-19 Patients

scientific article published on 01 September 2020

Longitudinal antibody and T cell responses in Ebola virus disease survivors and contacts: an observational cohort study

artículo científico publicado en 2020

Marburg Virus Evades Interferon Responses by a Mechanism Distinct from Ebola Virus

artículo científico publicado en 2010

Marburg virus regulates the IRE1/XBP1-dependent unfolded protein response to ensure efficient viral replication

artículo científico publicado en 2019

Polyclonal and convergent antibody response to Ebola virus vaccine rVSV-ZEBOV

artículo científico publicado en 2019

Recombinant Marburg virus expressing EGFP allows rapid screening of virus growth and real-time visualization of virus spread

artículo científico publicado en 2011

Reverse genetic characterization of the natural genomic deletion in SARS-Coronavirus strain Frankfurt-1 open reading frame 7b reveals an attenuating function of the 7b protein in-vitro and in-vivo

scientific article published on 24 August 2009

SARS-CoV-2 and SARS-CoV differ in their cell tropism and drug sensitivity profiles

artículo científico publicado en 2020

Safety and immunogenicity of a modified vaccinia virus Ankara vector vaccine candidate for Middle East respiratory syndrome: an open-label, phase 1 trial

scientific article published on 20 April 2020

Safety and immunogenicity of rVSVΔG-ZEBOV-GP Ebola vaccine in adults and children in Lambaréné, Gabon: A phase I randomised trial

artículo científico publicado en 2017

Serine-Arginine Protein Kinase 1 Regulates Ebola Virus Transcription

artículo científico publicado en 2020

Severe acute respiratory syndrome coronavirus triggers apoptosis via protein kinase R but is resistant to its antiviral activity

artículo científico publicado en 2008

Systems Vaccinology Identifies an Early Innate Immune Signature as a Correlate of Antibody Responses to the Ebola Vaccine rVSV-ZEBOV.

artículo científico publicado en 2017

Tetherin inhibits Nipah virus but not Ebola virus replication in fruit bat cells

artículo científico publicado en 2019

The effect of dose on the safety and immunogenicity of the VSV Ebola candidate vaccine: a randomised double-blind, placebo-controlled phase 1/2 trial

artículo científico publicado en 2015

The marburg virus 3' noncoding region structurally and functionally differs from that of ebola virus

artículo científico publicado en 2009

Transcriptional Regulation in Ebola Virus: Effects of Gene Border Structure and Regulatory Elements on Gene Expression and Polymerase Scanning Behavior

artículo científico publicado en 2015

Lista de obras de

A Monovalent Chimpanzee Adenovirus Ebola Vaccine Boosted with MVA

A Randomized, Blinded, Dose-Ranging Trial of an Ebola Virus Glycoprotein (EBOV GP) Nanoparticle Vaccine with Matrix-M™ Adjuvant in Healthy Adults

Adjuvant formulated virus-like particles expressing native-like forms of the Lassa virus envelope surface glycoprotein are immunogenic and induce antibodies with broadly neutralizing activity

Corrigendum: Differential transcriptional responses to Ebola and Marburg virus infection in bat and human cells

Cryo-electron tomography of Marburg virus particles and their morphogenesis within infected cells

Detectable Vesicular Stomatitis Virus (VSV)-Specific Humoral and Cellular Immune Responses Following VSV-Ebola Virus Vaccination in Humans

Development of a Cost-effective Ovine Polyclonal Antibody-Based Product, EBOTAb, to Treat Ebola Virus Infection

Development of an antibody capture ELISA using inactivated Ebola Zaire Makona virus

Differential transcriptional responses to Ebola and Marburg virus infection in bat and human cells

Dose-dependent T-cell Dynamics and Cytokine Cascade Following rVSV-ZEBOV Immunization

Electron tomography reveals the steps in filovirus budding

Epitopes of Naturally Acquired and Vaccine-induced Anti-Ebola Virus Glycoprotein Antibodies in Single Amino Acid Resolution

Establishment of fruit bat cells (Rousettus aegyptiacus) as a model system for the investigation of filoviral infection

Functional Characterization of Adaptive Mutations during the West African Ebola Virus Outbreak.

Generation of therapeutic antisera for emerging viral infections

Investigating the zoonotic origin of the West African Ebola epidemic

Longitudinal Isolation of Potent Near-Germline SARS-CoV-2-Neutralizing Antibodies from COVID-19 Patients

Longitudinal Isolation of Potent Near-Germline SARS-CoV-2-Neutralizing Antibodies from COVID-19 Patients

Longitudinal antibody and T cell responses in Ebola virus disease survivors and contacts: an observational cohort study

Marburg Virus Evades Interferon Responses by a Mechanism Distinct from Ebola Virus

Marburg virus regulates the IRE1/XBP1-dependent unfolded protein response to ensure efficient viral replication

Polyclonal and convergent antibody response to Ebola virus vaccine rVSV-ZEBOV

Recombinant Marburg virus expressing EGFP allows rapid screening of virus growth and real-time visualization of virus spread

Reverse genetic characterization of the natural genomic deletion in SARS-Coronavirus strain Frankfurt-1 open reading frame 7b reveals an attenuating function of the 7b protein in-vitro and in-vivo

SARS-CoV-2 and SARS-CoV differ in their cell tropism and drug sensitivity profiles

Safety and immunogenicity of a modified vaccinia virus Ankara vector vaccine candidate for Middle East respiratory syndrome: an open-label, phase 1 trial

Safety and immunogenicity of rVSVΔG-ZEBOV-GP Ebola vaccine in adults and children in Lambaréné, Gabon: A phase I randomised trial

Serine-Arginine Protein Kinase 1 Regulates Ebola Virus Transcription

Severe acute respiratory syndrome coronavirus triggers apoptosis via protein kinase R but is resistant to its antiviral activity

Systems Vaccinology Identifies an Early Innate Immune Signature as a Correlate of Antibody Responses to the Ebola Vaccine rVSV-ZEBOV.

Tetherin inhibits Nipah virus but not Ebola virus replication in fruit bat cells

The effect of dose on the safety and immunogenicity of the VSV Ebola candidate vaccine: a randomised double-blind, placebo-controlled phase 1/2 trial

The marburg virus 3' noncoding region structurally and functionally differs from that of ebola virus

Transcriptional Regulation in Ebola Virus: Effects of Gene Border Structure and Regulatory Elements on Gene Expression and Polymerase Scanning Behavior